News

BioTime Co-CEO Dr. Michael D. West to Present at World Advanced Therapies & Regenerative Medicine Congress on May 17 and 19

ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Co-Chief Executive Officer Michael D. West, Ph.D. will present at Terrapinn’s World Advanced Therapies & Regenerative Medicine Congress, May 17-19 at Business Design Centre in London.

2017-06-27T12:12:27+00:00